This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Sep 15;128(11):1525-8.

doi: 10.1182/blood-2016-02-699439. Epub 2016 Jul 11.

The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia

Hongming Zhu¹, Jiong Hu¹, Li Chen¹, Wei Zhou², Xiaoyang Li¹, Lining Wang¹, Xia Zhao¹, Yunxiang Zhang¹, Huijin Zhao¹, Aihua Wang¹, Yú Chen¹, Huiping Sun¹, Qiusheng Chen¹, Yù Chen¹, Weili Zhao¹, Jianqing Mi¹, Zhixiang Shen¹, Zhenyi Wang¹, Zhu Chen¹, Saijuan Chen¹, Junmin Li¹

Affiliations

Affiliations

¹ Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; and.
² Department of Internal Medicine, Singapore General Hospital, Singapore.

PMID: 27402972
DOI: 10.1182/blood-2016-02-699439

Free article

The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia

Hongming Zhu et al. Blood. 2016.

Free article

. 2016 Sep 15;128(11):1525-8.

doi: 10.1182/blood-2016-02-699439. Epub 2016 Jul 11.

Authors

Hongming Zhu¹, Jiong Hu¹, Li Chen¹, Wei Zhou², Xiaoyang Li¹, Lining Wang¹, Xia Zhao¹, Yunxiang Zhang¹, Huijin Zhao¹, Aihua Wang¹, Yú Chen¹, Huiping Sun¹, Qiusheng Chen¹, Yù Chen¹, Weili Zhao¹, Jianqing Mi¹, Zhixiang Shen¹, Zhenyi Wang¹, Zhu Chen¹, Saijuan Chen¹, Junmin Li¹

Affiliations

¹ Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; and.
² Department of Internal Medicine, Singapore General Hospital, Singapore.

PMID: 27402972
DOI: 10.1182/blood-2016-02-699439

No abstract available

PubMed Disclaimer

Similar articles

Arsenic trioxide for the treatment of acute promyelocytic leukemia.
Lam MS, Ignoffo RJ. Lam MS, et al. Cancer Pract. 2001 May-Jun;9(3):155-7. doi: 10.1046/j.1523-5394.2001.009003155.x. Cancer Pract. 2001. PMID: 11879303 No abstract available.
Arsenic trioxide and acute promyelocytic leukemia: clinical and biological.
Chen Z, Zhao WL, Shen ZX, Li JM, Chen SJ, Zhu J, Lallemand-Breittenbach V, Zhou J, Guillemin MC, Vitoux D, de Thé H. Chen Z, et al. Curr Top Microbiol Immunol. 2007;313:129-44. doi: 10.1007/978-3-540-34594-7_8. Curr Top Microbiol Immunol. 2007. PMID: 17217042 Review.
[Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia].
Lengfelder E, Schultheis B, Büchner T, Hehlmann R. Lengfelder E, et al. Dtsch Med Wochenschr. 2007 Feb 16;132(7):330-6. doi: 10.1055/s-2007-959329. Dtsch Med Wochenschr. 2007. PMID: 17286223 Review. German. No abstract available.
Arsenic trioxide newly joins treatment strategies for acute promyelocytic leukemia.
Kuriyama K. Kuriyama K. Intern Med. 2001 Dec;40(12):1165. doi: 10.2169/internalmedicine.40.1165. Intern Med. 2001. PMID: 11813833 No abstract available.
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.
Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY. Shen ZX, et al. Blood. 1997 May 1;89(9):3354-60. Blood. 1997. PMID: 9129042 Clinical Trial.

See all similar articles

Cited by

[The cure for acute promyelocytic leukemia and China's contributions].
Chen L, Chen SJ. Chen L, et al. Zhonghua Xue Ye Xue Za Zhi. 2025 May 14;46(5):377-384. doi: 10.3760/cma.j.cn121090-20250307-00119. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40623894 Free PMC article. Review. Chinese.
At What Point Are Long-Term (>5 Years) Survivors of APL Safe? A Study from the SEER Database.
Yin XJ, Wang R, Shen HS, Jin J, Zhu HH. Yin XJ, et al. Cancers (Basel). 2023 Jan 17;15(3):575. doi: 10.3390/cancers15030575. Cancers (Basel). 2023. PMID: 36765533 Free PMC article.
Treatment for relapsed acute promyelocytic leukemia.
Yanada M. Yanada M. Ann Hematol. 2022 Dec;101(12):2575-2582. doi: 10.1007/s00277-022-04954-0. Epub 2022 Aug 16. Ann Hematol. 2022. PMID: 35972562 Review.
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.
McCulloch D, Brown C, Iland H. McCulloch D, et al. Onco Targets Ther. 2017 Mar 14;10:1585-1601. doi: 10.2147/OTT.S100513. eCollection 2017. Onco Targets Ther. 2017. PMID: 28352191 Free PMC article. Review.
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide.
Zheng Y, Mao YF, Zhao HJ, Chen L, Wang LN, Zhang YX, Hu J, Li JM, Li XY, Zhu HM. Zheng Y, et al. Exp Hematol Oncol. 2021 Feb 6;10(1):10. doi: 10.1186/s40164-021-00205-6. Exp Hematol Oncol. 2021. PMID: 33549147 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information